搜尋結果
文章
Pan, Y. ,
Chiu, Y. H. ,
Chiu, S. C. ,
Cho, D. Y. ,
Lee, L. M. ,
Wen, Y. C. ,
Whang-Peng, J. ,
Hsiao, C. H. &
Shih, P. H. ,
7月 2020 ,
於: Anticancer Research. 40 ,
7 ,
p. 3865-3872 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cytokine-Induced Killer Cells
100%
Carboplatin
73%
Ovarian Neoplasms
59%
T-Lymphocytes
40%
Cell- and Tissue-Based Therapy
10%
Peng, C. C. ,
Chyau, C. C. ,
Wang, H. E. ,
Chang, C. H. ,
Chen, K. C. ,
Chou, K. Y. &
Peng, R. Y. ,
2013 ,
於: BioMed Research International. 2013 , 579859.
研究成果: 雜誌貢獻 › 文章 › 同行評審
ferulic acid
100%
Ferulic Acid
84%
Bioactivity
50%
Antihypercholesterolemic
44%
Cell Line
41%
honokiol
100%
Autophagy
60%
Glioma
57%
Data Analysis
46%
In Vitro Techniques
27%
Yan, S. J. ,
Lee, Y. F. ,
Ting, H. J. ,
Liu, N. C. ,
Liu, S. ,
Lin, S. J. ,
Yeh, S. D. ,
Li, G. &
Chang, C. ,
2012 ,
於: Cellular and Molecular Biology Letters. 17 ,
2 ,
p. 309-322 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nuclear Receptor Subfamily 2, Group C, Member 2
100%
Ionizing Radiation
63%
Cytoplasmic and Nuclear Receptors
53%
Small Interfering RNA
28%
Protective
17%
Chen, S. S. ,
Hu, C. ,
Liu, C. H. ,
Chen, Y. H. ,
Ahamad, T. ,
Alshehri, S. M. ,
Huang, P. H. &
Wu, K. C. W. ,
10月 5 2020 ,
於: Journal of Hazardous Materials. 397 , 122431.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Metal-Organic Frameworks
100%
Phenols
70%
Phenol
65%
Platinum
64%
platinum
62%
Kang, Y-N. ,
Chang, C-H. ,
Kao, C-C. ,
Chen, C-Y. &
Wu, C-C. ,
1月 1 2019 ,
於: PLoS One. 14 ,
1 ,
p. e0209155 e0209155.
研究成果: 雜誌貢獻 › 文章 › 同行評審
self-efficacy
100%
Clinical Competence
74%
Self Efficacy
64%
learning
57%
Learning
46%
Lin, T. H. ,
Lee, S. O. ,
Niu, Y. ,
Xu, D. ,
Liang, L. ,
Li, L. ,
Yeh, S. D. ,
Fujimoto, N. ,
Yeh, S. &
Chang, C. ,
7月 5 2013 ,
於: Journal of Biological Chemistry. 288 ,
27 ,
p. 19359-19369 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Enzalutamide
100%
Bicalutamide
90%
bicalutamide
79%
MDV 3100
78%
Androgen
67%
Bamodu, O. A. ,
Tzou, K. Y. ,
Lin, C. D. ,
Hu, S. W. ,
Wang, Y. H. ,
Wu, W. L. ,
Chen, K. C. &
Wu, C. C. ,
7月 2 2021 ,
於: Cancers. 13 ,
14 , 3478.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Disease Susceptibility
100%
Testosterone
79%
Prostatic Neoplasms
71%
Recurrence
51%
Neoplasm Metastasis
23%
Tsai, M. Y. ,
Yeh, S. D. ,
Wang, R. S. ,
Yeh, S. ,
Zhang, C. ,
Lin, H. Y. ,
Tzeng, C. R. &
Chang, C. ,
12月 12 2006 ,
於: Proceedings of the National Academy of Sciences of the United States of America. 103 ,
50 ,
p. 18975-18980 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
mouse AR protein
100%
Spermatogenesis
61%
Androgen Receptors
61%
Fertility
53%
Testis
50%
Pan, K. F. ,
Lee, W. J. ,
Chou, C. C. ,
Yang, Y. C. ,
Chang, Y. C. ,
Chien, M. H. ,
Hsiao, M. &
Hua, K. T. ,
2月 15 2021 ,
於: EMBO Journal. 40 ,
4 , e105450.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Catenins
100%
Prostatic Neoplasms
62%
Endothelial Cells
58%
Molecule
27%
Wnt Signaling Pathway
25%
Kuei, C. H. ,
Lin, H. Y. ,
Lin, M. H. ,
Lee, H. H. ,
Lin, C. H. ,
Lee, W. J. ,
Chen, Y. L. ,
Lu, L. S. ,
Zheng, J. Q. ,
Hung, R. C. ,
Chiu, H. W. ,
Chen, K. C. &
Lin, Y. F. ,
12月 1 2020 ,
於: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1866 ,
12 ,
p. 165954 165954.
研究成果: 雜誌貢獻 › 文章 › 同行評審
DNA polymerase theta
100%
Docetaxel
57%
Castration
56%
Prostatic Neoplasms
40%
Luciferases
16%
Lu, C. F. ,
Chen, C. Y. ,
Lee, L. M. ,
Lin, K. H. ,
Lin, Y. W. ,
Hsiao, C. H. &
Wen, Y. C. ,
3月 1 2018 ,
於: Urological Science. 29 ,
2 ,
p. 86-90 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Urinary Retention
100%
Oxidoreductases
76%
Hyperplasia
74%
Prostate
70%
International Classification of Diseases
54%
Tung, M. C. ,
Wen, Y. C. ,
Wang, S. S. ,
Lin, Y. W. ,
Liu, Y. C. ,
Yang, S. F. &
Chien, M. H. ,
7月 30 2018 ,
於: International Journal of Medical Sciences. 15 ,
11 ,
p. 1187-1193 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dopamine D2 Receptors
100%
Dopamine Receptors
95%
Genetic Variation
81%
Carcinoma
56%
Population
33%
Chen, C. Y. ,
Lee, L. M. ,
Yu, H. W. ,
Lee, S. P. ,
Lee, H. L. ,
Lin, Y. W. ,
Wen, Y. C. ,
Chen, Y. J. ,
Chen, C. P. &
Tsai, J. T. ,
2017 ,
於: Journal of X-Ray Science and Technology. 25 ,
3 ,
p. 465-477 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Radiotherapy
100%
Radiosurgery
89%
radiation therapy
81%
cancer
75%
Prostatic Neoplasms
64%
Chang, J. H. ,
Cheng, C. W. ,
Yang, Y. C. ,
Chen, W. S. ,
Hung, W. Y. ,
Chow, J. M. ,
Chen, P. S. ,
Hsiao, M. ,
Lee, W. J. &
Chien, M. H. ,
8月 22 2018 ,
於: Journal of Experimental and Clinical Cancer Research. 37 ,
1 ,
p. 199 199.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Apigenin
100%
Dipeptidyl Peptidase 4
96%
Gastropoda
95%
ErbB Receptors
67%
Lung Neoplasms
56%
Liu, M. ,
Bamodu, O. A. ,
Kuo, K. T. ,
Lee, W. H. ,
Lin, Y. K. ,
Wu, A. T. H. ,
M, H. ,
Tzeng, Y. M. ,
Yeh, C. T. &
Tsai, J. T. ,
2018 ,
於: American Journal of Chinese Medicine. 46 ,
4 ,
p. 891-910 20 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
ovatodiolide
100%
Diterpenes
63%
Catenins
59%
Neoplastic Stem Cells
50%
Liver Neoplasms
47%
Chien, M. H. ,
Yang, W. E. ,
Yang, Y. C. ,
Ku, C. C. ,
Lee, W. J. ,
Tsai, M. Y. ,
Lin, C. W. &
Yang, S. F. ,
3月 2020 ,
於: Cancers. 12 ,
3 , 703.
研究成果: 雜誌貢獻 › 文章 › 同行評審
demethoxycurcumin
100%
Squamous Cell Carcinoma
48%
Cell Death
43%
Heme
38%
Gefitinib
28%
Cheng, C. J. ,
Chen, K. C. ,
Chen, W. Y. &
Su, S. J. ,
2001 ,
於: Journal of the Formosan Medical Association = Taiwan yi zhi. 100 ,
10 ,
p. 707-711 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Prostate
100%
Adenocarcinoma
93%
Neoplasms
38%
Hematuria
31%
Urethral Obstruction
22%
Lin, H. P. ,
Ho, H. M. ,
Chang, C. W. ,
Yeh, S. D. ,
Su, Y. W. ,
Tan, T. H. &
Lin, W. J. ,
12月 2019 ,
於: FASEB Journal. 33 ,
12 ,
p. 14653-14667 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Androgen
100%
Androgen Receptors
85%
ErbB Receptors
75%
Prostatic Neoplasms
63%
Dephosphorylation
59%
Urinary Bladder
100%
Carcinoma
82%
Race Factors
61%
Intravesical Administration
57%
Mycobacterium bovis
44%
Hsiao, C. Y. ,
Wu, J. C. ,
Lin, P. C. ,
Yang, P. Y. ,
Liao, F. ,
Guo, S. L. &
Hou, W. H. ,
2022 , (接受/付印)
於: Patient Education and Counseling. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Shared Decision Making
100%
Education
42%
Problem-Based Learning
35%
Occupational Groups
28%
Interviews
26%
Tsai, P. S. ,
Wang, C. C. ,
Lan, Y. H. ,
Tsai, H. W. ,
Hsiao, C. Y. ,
Wu, J. C. ,
Sheen-Chen, S. M. &
Hou, W. H. ,
2022 , (接受/付印)
於: Patient Education and Counseling. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Self Efficacy
100%
Randomized Controlled Trials
87%
Breast Neoplasms
82%
Communication
72%
Decision Making
53%
Tong, Y. S. ,
Wu, C-C. ,
Bai, C-H. ,
Lee, H. C. ,
Liang, H-H. ,
Kuo, L-J. ,
Wei, P-L. &
Tam, K-W. ,
2014 ,
於: Hernia. 18 ,
2 ,
p. 177-183 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Inguinal Hernia
100%
Bupivacaine
96%
Herniorrhaphy
95%
Analgesia
78%
Postoperative Pain
68%
Shigemura, K. ,
Kitagawa, K. ,
Chen, K. C. ,
Sung, S. Y. &
Fujisawa, M. ,
6月 1 2020 ,
於: Urologia Internationalis. 104 ,
5-6 ,
p. 356-360 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dutasteride
100%
Morcellation
99%
Solid-State Lasers
70%
Prostate
52%
Prostate-Specific Antigen
43%
Huang, C. Y. ,
Chu, J. S. ,
Pu, Y. S. ,
Yang, H. Y. ,
Wu, C. C. ,
Chung, C. J. &
Hsueh, Y. M. ,
6月 2011 ,
於: Journal of Urology. 185 ,
6 ,
p. 2040-2044 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Arsenic
100%
Renal Cell Carcinoma
80%
Glomerular Filtration Rate
79%
Hypertension
27%
monomethylarsonic acid
18%
Lin, Y. C. ,
Lai, Y. J. ,
Lin, Y. C. ,
Peng, C. C. ,
Chen, K. C. ,
Chuang, M. T. ,
Wu, M. S. &
Chang, T. H. ,
8月 2019 ,
於: Journal of Cachexia, Sarcopenia and Muscle. 10 ,
4 ,
p. 756-766 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Bariatric Surgery
100%
Glomerular Filtration Rate
85%
Chronic Renal Insufficiency
82%
Weight Loss
74%
Body Mass Index
16%
Lai, C-H. ,
Wu, Y. W. ,
Yeh, S-D. ,
Lin, Y. H. &
Tsai, Y-H. ,
2014 ,
於: Evidence-based Complementary and Alternative Medicine. 2014 , 924560.
研究成果: 雜誌貢獻 › 文章 › 同行評審
6-hydroxyflavone
100%
hydroxide ion
53%
Osteoblasts
44%
Mitogen-Activated Protein Kinase 9
18%
flavone
16%
Lin, Y. C. ,
Lin, J. W. ,
Wu, M. S. ,
Chen, K. C. ,
Peng, C. C. &
Kang, Y. N. ,
12月 2017 ,
於: PLoS ONE. 12 ,
12 , e0188975.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Angiotensin Receptor Antagonists
100%
Calcium Channel Blockers
96%
Renin-Angiotensin System
92%
Angiotensin-Converting Enzyme Inhibitors
87%
Chronic Renal Insufficiency
81%
Lin, Y. C. ,
Lin, Y. C. ,
Peng, C. C. ,
Chen, K. C. ,
Chen, H. H. ,
Fang, T. C. ,
Sung, S. Y. &
Wu, M. S. ,
3月 3 2018 ,
於: Nutrients. 10 ,
3 , 300.
研究成果: 雜誌貢獻 › 文章 › 同行評審
renal function
100%
Peritoneal Dialysis
90%
dialysis
85%
cholesterol
63%
Cholesterol
61%
Wang, K. H. ,
Wan, R. ,
Chiu, L. H. ,
Tsai, Y. H. ,
Fang, C. L. ,
Bowley, J. F. ,
Chen, K. C. ,
Shih, H. N. &
Lai, W. F. T. ,
5月 1 2018 ,
於: PLoS One. 13 ,
5 , e0196779.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Bioreactors
100%
knees
99%
cartilage
86%
Knee Joint
84%
bioreactors
81%
Pan, Y. ,
Hong, Y. C. ,
Hsiao, C. H. ,
Shih, H. J. ,
Huang, S. H. ,
Wu, S. C. ,
Chang, C. P. ,
Chiu, S. C. ,
Cho, D. Y. &
Shih, P. H. ,
10月 2021 ,
於: Anticancer Research. 41 ,
10 ,
p. 4957-4968 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chemoradiotherapy
100%
Urinary Bladder
74%
Carcinoma
61%
Neoplasm Metastasis
57%
Neoplastic Stem Cells
39%
Yeh, S. D. ,
Lin, B. S. ,
Chen, S. C. ,
Chen, C. H. ,
Gustafson, K. J. ,
Bourbeau, D. J. ,
Rajneesh, C. P. &
Peng, C. W. ,
1月 1 2019 ,
於: Evidence-based Complementary and Alternative Medicine. 2019 , 1248342.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Genitalia
100%
Spinal Cord
88%
Urinary Bladder
86%
Spinal Cord Injuries
44%
Reflex
13%
Lin, C. H. ,
Hsieh, M. J. ,
Lee, H. L. ,
Yang, S. F. ,
Su, S. C. ,
Lee, W. J. &
Chou, Y. E. ,
1月 1 2020 ,
於: Journal of Cancer. 11 ,
6 ,
p. 1641-1647 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Colonic Neoplasms
100%
Hepatocellular Carcinoma
88%
Neoplasm Metastasis
68%
Odds Ratio
31%
Single Nucleotide Polymorphism
30%
Tai, T. E. ,
Wu, C. C. ,
Kang, Y. N. &
Wu, J. C. ,
9月 1 2020 ,
於: Surgical endoscopy. 34 ,
9 ,
p. 4020-4029 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Prostatectomy
100%
Meta-Analysis
72%
Systematic Reviews
71%
Margins of Excision
64%
Odds Ratio
31%
Chen, L-S. ,
Chen, W-C. ,
Kang, Y-N. ,
Wu, C-C. ,
Tsai, L-W. &
Liu, M-Z. ,
2月 2019 ,
於: Surgical Endoscopy and Other Interventional Techniques. p. 1-11 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Inguinal Hernia
100%
Herniorrhaphy
95%
Hernia
91%
Meta-Analysis
63%
Systematic Reviews
62%
Lin, K. H. ,
Lin, Y. W. ,
Wen, Y-C. &
Lee, L. M. ,
12月 2012 ,
於: Aging Male. 15 ,
4 ,
p. 246-252 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tamsulosin
100%
Prostatic Hyperplasia
75%
Tablets
62%
Lower Urinary Tract Symptoms
41%
Safety
39%
Tzou, K. Y. ,
Hu, S. W. ,
Bamodu, O. A. ,
Wang, Y. H. ,
Wu, W. L. &
Wu, C. C. ,
11月 2021 ,
於: Biomedicines. 9 ,
11 , 1670.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Phosphodiesterase V Inhibitor
100%
Refraction
81%
Erectile Dysfunction
68%
Safety
54%
Extracorporeal Shockwave Therapy
49%
Chou, Y. T. ,
Lin, H. H. ,
Lien, Y. C. ,
Wang, Y. H. ,
Hong, C. F. ,
Kao, Y. R. ,
Lin, S. C. ,
Chang, Y. C. ,
Lin, S. Y. ,
Chen, S. J. ,
Chen, H. C. ,
Yeh, S. D. &
Wu, C. W. ,
11月 1 2010 ,
於: Cancer Research. 70 ,
21 ,
p. 8822-8831 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Extracellular Signal-Regulated MAP Kinases
100%
ErbB Receptors
87%
Lung Neoplasms
73%
Carcinogenesis
70%
Lung
49%
Lin, S. R. ,
Wen, Y. C. ,
Yeh, H. L. ,
Jiang, K. C. ,
Chen, W. H. ,
Mokgautsi, N. ,
Huang, J. ,
Chen, W. Y. &
Liu, Y. N. ,
10月 29 2020 ,
於: Oncogene. 39 ,
44 ,
p. 6757-6775 19 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
OSM-LIF Receptors
100%
Castration
69%
ErbB Receptors
59%
Prostatic Neoplasms
49%
Up-Regulation
22%
Interstitial Cystitis
100%
Endometriosis
77%
Population
28%
Chronic Fatigue Syndrome
5%
Pelvic Pain
5%
Li, Y. R. ,
Tsao, S. H. ,
Chen, C. L. ,
Hou, C. P. ,
Tsui, K. H. ,
Juang, H. H. &
Lin, Y. H. ,
11月 2022 ,
於: Journal of Clinical Medicine. 11 ,
22 , 6808.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Urinary Bladder Neck Obstruction
100%
Testosterone
65%
Prostate
62%
Lower Urinary Tract Symptoms
17%
Thulium
12%
Chen, Y. T. ,
Yeh, H. C. ,
Lee, H. Y. ,
Hsieh, P. F. ,
Chou, E. C. L. ,
Tsai, Y. C. ,
Hong, J. H. ,
Huang, C. Y. ,
Jiang, Y. H. ,
Lee, Y. K. ,
Tseng, J. S. ,
Yu, C. C. ,
Chiang, B. J. ,
Hsueh, T. Y. ,
Wu, C. C. &
Tsai, C. Y. ,
2022 , (接受/付印)
於: Asian Journal of Surgery. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Neoplasms
32%
Hydronephrosis
14%
Urinary Bladder
10%
Cell Biology
5%
Chen, Y. T. ,
Yu, C. C. ,
Yeh, H. C. ,
Lee, H. Y. ,
Jiang, Y. H. ,
Lee, Y. K. ,
Kuei, C. H. ,
Wu, C. C. ,
Huang, C. Y. ,
Lin, W. Y. ,
Yang, C. K. &
Tsai, Y. C. ,
12月 2021 ,
於: Scientific Reports. 11 ,
1 , 4040.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Nephroureterectomy
100%
Carcinoma
48%
Survival
40%
Disease-Free Survival
23%
Taiwan
12%
Hsu, M. Y. ,
Hsieh, C. H. ,
Huang, Y. T. ,
Chu, S. Y. ,
Chen, C. M. ,
Lee, W. J. &
Liu, S. J. ,
7月 1 2021 ,
於: Cancers. 13 ,
13 , 3350.
研究成果: 雜誌貢獻 › 文章 › 同行評審
dilactide
100%
Nanofibers
86%
Triple Negative Breast Neoplasms
80%
Paclitaxel
67%
Drug Therapy
39%
Ho, C. H. ,
Fan, C. K. ,
Wu, C. C. ,
Yu, H. J. ,
Liu, H. T. ,
Chen, K. C. ,
Liu, S. P. &
Cheng, P. C. ,
1月 1 2019 ,
於: Journal of Microbiology, Immunology and Infection. 54 ,
2 ,
p. 193-205 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Uropathogenic Escherichia coli
100%
Escherichia coli Infections
90%
Sugars
68%
Urinary Tract Infections
15%
Diabetes Mellitus
12%
Wu, C. C. ,
Chen, M. C. ,
Huang, Y. K. ,
Huang, C. Y. ,
Lai, L. A. ,
Chung, C. J. ,
Shiue, H. S. ,
Pu, Y. S. ,
Lin, Y-C. ,
Han, B. C. ,
Wang, Y. H. &
Hsueh, Y. M. ,
9月 2013 ,
於: Journal of the Formosan Medical Association. 112 ,
9 ,
p. 554-560 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Arsenic
100%
Tobacco Smoke Pollution
80%
Smoke
79%
Tobacco
79%
Methylation
75%
Ho, C-H. ,
Wu, C. C. ,
Chen, K. C. ,
Jaw, F. S. ,
Yu, H. J. &
Liu, S. P. ,
4月 2 2016 ,
於: Aging Male. 19 ,
2 ,
p. 96-101 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Libido
100%
Erectile Dysfunction
81%
Testosterone
66%
Cardiovascular Diseases
54%
Logistic Models
11%
Liu, M. C. ,
Chen, W. H. ,
Wu, L. C. ,
Hsu, W. C. ,
Lo, W. C. ,
Yeh, S. D. ,
Wang, M. F. ,
Zeng, R. &
Deng, W. P. ,
1月 1 2014 ,
於: Tissue Engineering - Part C: Methods. 20 ,
1 ,
p. 1-10 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nucleus Pulposus
100%
Platelets
98%
Tissue engineering
95%
Intervertebral Disc
88%
Tissue Engineering
74%
Tian, Y. S. ,
Chen, K. C. ,
Zulkefli, N. D. ,
Maner, R. S. &
Hsieh, C. L. ,
1月 1 2018 ,
於: Molecules. 3327.
研究成果: 雜誌貢獻 › 文章 › 同行評審
genipin
100%
Genipin
92%
Fluoxetine
89%
Hep G2 Cells
67%
proteins
50%
Chronic Renal Insufficiency
100%
Doxorubicin
67%
Apoptosis
66%
Kidney
58%
Caspase 9
41%